Assessment of the Safety and Effectiveness of Stem Cell Treatments for Dry Eye Syndrome Associated with Sjögren’s Syndrome: A Systematic Review and Meta-Analysis - Takeaways - MDSpire

Assessment of the Safety and Effectiveness of Stem Cell Treatments for Dry Eye Syndrome Associated with Sjögren’s Syndrome: A Systematic Review and Meta-Analysis

  • By

  • Jizhong Zhang

  • Wenshuang Wang

  • Changyong Li

  • April 29, 2026

  • 0 min

Share

  • 1

    Stem cell therapy shows promise in treating dry eye syndrome associated with Sjögren’s syndrome, though it lacks clinical approval.

  • 2

    The meta-analysis included five studies with 114 patients, demonstrating significant improvements in OSDI and Schirmer test scores post-treatment.

  • 3

    Adverse events included injection pain, ocular discomfort, and blurred vision, with varying incidence rates observed at 4 weeks.

  • 4

    Results indicated a significant reduction in OSDI scores by -15.10 and an increase in NIKBUT first scores by 3.26 post-treatment.

  • 5

    The findings suggest careful consideration of benefits and risks is essential before clinical application of stem cell therapies.

Original Source(s)

Assessment of the Safety and Effectiveness of Stem Cell Treatments for Dry Eye Syndrome Associated with Sjögren’s Syndrome: A Systematic Review and Meta-Analysis

  • by Jizhong Zhang, Wenshuang Wang, Changyong Li

  • April 29, 2026

Related Content

Refractive Surgery Review

When refractive surgery doesn’t go to plan: a definitive guide to managing complications

  • January 20, 2026

  • 3 min
CSO Meeting 2026 Highlights Convergence of Innovation and Clinical Practice

More than 300 professionals gathered for three days of innovation, education, and collaboration, highlighting the latest advances in ophthalmic technology and clinical practice

  • May 12, 2026

  • 2 min
Dry Eye Across Autoimmune Diseases

The nationwide analysis found the highest rates of dry eye disease among patients with Sjögren’s syndrome.